Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$537,772
-$4,840,234 QoQ
Shares Held
7,967
-94.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#114
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Derivatives in ANAB
reported options exposure · as of Mar 31, 2021CallValue
$7,240
CallShares
504
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. ANAB ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in ANAB
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537,772 | 7,967 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,378,006 | 96,971 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $7,990,619 | 164,823 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,235,395 | 105,663 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $82,117 | 3,699 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $475,661 | 25,587 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $306,189 | 23,126 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,214,648 | 66,109 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,114 | 1,082 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $372,029 | 16,520 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $448,813 | 20,953 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $427,392 | 23,797 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $395,226 | 19,431 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $708,616 | 32,565 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $489,332 | 15,790 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $770,480 | 30,203 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $101,174 | 4,984 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $70,310 | 2,842 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $268,722 | 7,733 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $135,844 | 5,009 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $72,267 | 2,787 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $7,240 | 336 | Call | Defined | 2021-05-07 | |
| 2021-03-31 | $284,439 | 13,199 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $47,278 | 2,199 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $70,578 | 4,785 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $81,362 | 3,642 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $306,451 | 21,688 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||